Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 5
159
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

The effect of simvastatin on gene expression of low-density lipoprotein receptor, sterol regulatory element-binding proteins, stearoyl-CoA desaturase 1 mRNA in rat hepatic tissues

, , , &
Pages 1383-1390 | Received 13 Apr 2020, Accepted 18 May 2020, Published online: 09 Jul 2020

References

  • Attie, A.D., et al., 2002. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. Journal of lipid research, 43 (11), 1899–1907.
  • Balakumar, P., et al., 2007. Experimental models for vascular endothelial dysfunction. Trends in medical research, 2 (1), 12–20.
  • Barter, P.J., et al., 2010. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. Journal of lipid research, 51 (6), 1546–1553.
  • Bilheimer, D.W., et al., 2004. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholeserolemia heterozygotes. Atherosclerosis Supplements, 5 (3), 61–65.
  • Bonfleur, M.L., et al., 2010. Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity. Biochimica et biophysica acta, 1801 (2), 183–190.
  • Boucher, P., et al., 1998. Effect of dietary cholesterol on low density lipoprotein-receptor, 3-hydroxy-3-methylglutaryl-CoA reductase, and low density lipoprotein receptor-related protein mRNA expression in healthy humans. Lipids, 33 (12), 1177–1186.
  • Brault, M., et al., 2014. Statin treatment and new-onset diabetes: a review of proposed mechanisms. Metabolism: clinical and experimental, 63 (6), 735–745.
  • Brown, M.S. and Goldstein, J.L., 1979. Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proceedings of the national academy of sciences of the United States of America, 76 (7), 3330–3337.
  • Brunham, L.R., et al., 2008. Cholesterol in islet dysfunction and type 2 diabetes. Journal of clinical investigation, 118 (2), 403–408.
  • Carter, A.A., et al., 2013. Risk of incident diabetes among patients treated with statins: population based study. BMJ (Clinical Research ed.), 346, f2610.
  • Chang, T., Chang, C.C., and Cheng, D., 1997. Acyl-coenzyme A:cholesterol acyltransferase. Annual review of biochemistry, 66 (1), 613–638.
  • Clarke, S.D., 2001. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. The journal of nutrition, 131 (4), 1129–1132.
  • Cui, Y., et al., 2005. A comparative study of efficacy of tibolone and simvastatin on atherosclerosis in ovariectomized cholesterol-fed rabbits. Maturitas, 50 (4), 337–343.
  • d Oliveira, R.B., et al., 2014. Impaired compensatory beta-cell function and growth in response to high-fat diet in LDL receptor knockout mice. International journal of experimental pathology, 95 (4), 296–308.
  • Diraison, F., et al., 2002. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. American journal of physiology – endocrinology and metabolism, 282 (1), E46–E51.
  • Dobrzyn, P., et al., 2010. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice. Journal of lipid research, 51 (8), 2202–2210.
  • Dobrzyn, P., Jazurek, M., and Dobrzyn, A., 2010. Stearoyl-CoA desaturase and insulin signaling-what is the molecular switch? Biochimica et biophysica acta, 1797 (6–7), 1189–1194.
  • Eckel, R.H., Grundy, S.M., and Zimmet, P.Z., 2005. The metabolic syndrome. Lancet (London, England), 365 (9468), 1415–1428.
  • Ericsson, J., et al., 1996. Sterol regulatory element binding protein binds to a cis element in the promoter of the farnesyl diphosphate synthase gene. Proceedings of the national academy of sciences of the United States of America, 93 (2), 945–950.
  • Ericsson, J., et al., 1997. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. The journal of biological chemistry, 272 (11), 7298–7305.
  • Festing, M.F. and Altman, D.G., 2002. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR journal, 43 (4), 244–258.
  • Fryirs, M., Barter, P.J., and Rye, K.-A., 2009. Cholesterol metabolism and pancreatic beta-cell function. Current opinion in lipidology, 20 (3), 159–164.
  • Germershausen, J.I., et al., 1989. Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Biochemical and biophysical research communications, 158 (3), 667–675.
  • Gouni-Berthold, I., et al., 2008. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men. Atherosclerosis, 198 (1), 198–207.
  • Horton, J.D., et al., 1998. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. The journal of clinical investigation, 101 (11), 2331–2339.
  • Horton, J.D., Goldstein, J.L., and Brown, M.S., 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The journal of clinical investigation, 109 (9), 1125–1131.
  • Inoue, J., Sato, R., and Maeda, M., 1998. Multiple DNA elements for sterol regulatory element-binding protein and NF-Y are responsible for sterol-regulated transcription of the genes for human 3-hydroxy-3-methylglutaryl coenzyme A synthase and squalene synthase. Journal of biochemistry, 123 (6), 1191–1198.
  • Istvan, E.S. and Deisenhofer, J., 2001. Structural mechanism for statin inhibition of HMG-CoA reductase. Science (New York, N.Y.), 292 (5519), 1160–1164.
  • Ito, B., et al., 2009. Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys. British journal of pharmacology, 156 (3), 454–465.
  • Jensen-Urstad, A.P. and Semenkovich, C.F., 2012. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochimica et biophysica acta, 1821 (5), 747–753.
  • Jula, A., et al., 2005. Effects of diet and simvastatin on fatty acid composition in hypercholesterolemic men: a randomized controlled trial. Arteriosclerosis, thrombosis, and vascular biology, 25 (9), 1952–1959.
  • Jump, D.B. and Clarke, S.D., 1999. Regulation of gene expression by dietary fat. Annual review of nutrition, 19, 63–90.
  • Kastelein, J.J., et al., 2008. Simvastatin with or without ezetimibe in familial hypercholesterolemia. New England journal of medicine, 358 (14), 1431–1443.
  • Kolehmainen, M., et al., 2001. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obesity research, 9 (11), 706–712.
  • Kovanen, P.T., et al., 1981. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proceedings of the national academy of sciences of the United States of America, 78 (2), 1194–1198.
  • Krause, B.R. and Newton, R.S., 1995. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis, 117 (2), 237–244.
  • Kruit, J.K., et al., 2010. Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice. Diabetologia, 53 (6), 1110–1119.
  • Liang, G., et al., 2002. Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. The journal of biological chemistry, 277 (11), 9520–9528.
  • Liao, F.H., et al., 2007. Effectiveness of a soy-based compared with a traditional low-calorie diet on weight loss and lipid levels in overweight adults. Nutrition, 23 (7–8), 551–556.
  • Lin, C.-P., et al., 2015. Simvastatin attenuates oxidative stress, NF-κB activation, and artery calcification in LDLR-/- mice fed with high fat diet via down-regulation of tumor necrosis factor-α and TNF receptor 1. PLoS one, 10 (12), e0143686.
  • Madsen, C.S., et al., 2008. The Guinea pig as a preclinical model for demonstrating the efficacy and safety of statins. The journal of pharmacology and experimental therapeutics, 324 (2), 576–586.
  • Magana, M.M. and Osborne, T.F., 1996. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty-acid synthase promoter. The journal of biological chemistry, 271 (51), 32689–32694.
  • Magana, M.M., et al., 1997. Sterol regulation of acetyl coenzyme A carboxylase promoter requires two interdependent binding sites for sterol regulatory element binding proteins. Journal of lipid research, 38 (8), 1630–1638.
  • Mahan, L., 1998. Scott-Stump, Krause-Alimentos, Nutrição e Dietoterapia. São Paulo: ROCA.
  • Mao, J., et al., 2006. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proceedings of the national academy of sciences of the United States of America, 103 (22), 8552–8557.
  • Miao, J., et al., 2014. Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins. Journal of lipid research, 55 (4), 659–667.
  • Miyazaki, M., et al., 2000. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. The journal of biological chemistry, 275 (39), 30132–30138.
  • Mune, M., et al., 1999. Effect of dietary fish oil, vitamin E, and probucol on renal injury in the rat. Journal of nutritional biochemistry, 10 (9), 539–546.
  • Ngo Sock, E.T., Chapados, N.A., and Lavoie, J.M., 2014. LDL receptor and Pcsk9 transcripts are decreased in liver of ovariectomized rats: effects of exercise training. Hormone and metabolic research, 46 (08), 550–555.
  • Ntambi, J.M., 1999. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. Journal of lipid research, 40 (9), 1549–1558.
  • Osborne, T.F., 2000. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. The journal of biological chemistry, 275 (42), 32379–32382.
  • Osborne, T.F. and Espenshade, P.J., 2009. Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it's been. Genes & development, 23 (22), 2578–2591.
  • Paton, C.M. and Ntambi, J.M., 2010. Loss of stearoyl-CoA desaturase activity leads to free cholesterol synthesis through increased Xbp-1 splicing. American journal of physiology. Endocrinology and metabolism, 299 (6), E1066–E1075.
  • Pincus, J., 1998. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). The American journal of cardiology, 82 (3), 406–407.
  • Pitha, J., et al., 2010. Antiatherogenic effect of simvastatin is not due to decrease of LDL cholesterol in ovariectomized golden Syrian hamster. Physiological research, 59 (3), 401–406.
  • Pocathikorn, A., et al., 2007. LDL-receptor mRNA expression in men is downregulated within an hour of an acute fat load and is influenced by genetic polymorphism. The journal of nutrition, 137 (9), 2062–2067.
  • Poudyal, H., et al., 2012. Lipid redistribution by α-linolenic acid-rich chia seed inhibits stearoyl-CoA desaturase-1 and induces cardiac and hepatic protection in diet-induced obese rats. The journal of nutritional biochemistry, 23 (2), 153–162.
  • Powell, E.E. and Kroon, P.A., 1994. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. Journal of clinical investigation, 93 (5), 2168–2174.
  • Raal, J., 2009. Hypercholesterolaemia in children and young adults–current management. Journal of endocrinology, metabolism and diabetes of South Africa, 14 (1), 9–12.
  • Rader, D.J. and Hobbs, H.H., 2005. Disorders of lipoprotein metabolism. Harrisons principles of internal medicine, 16 (2), 2286.
  • Rutti, S., et al., 2009. Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology, 150 (10), 4521–4530.
  • Rzouq, F.S., et al., 2010. Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. The American journal of the medical sciences, 340 (2), 89–93.
  • Sato, R., 2010. Sterol metabolism and SREBP activation. Archives of biochemistry and biophysics, 501 (2), 177–181.
  • Sattar, N. and Taskinen, M.-R., 2012. Statins are diabetogenic – myth or reality? Atherosclerosis. Supplements, 13 (1), 1–10.
  • Scharnagl, H., et al., 2001. Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochemical pharmacology, 62 (11), 1545–1555.
  • Shimano, H., et al., 1997. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. The journal of clinical investigation, 99 (5), 846–854.
  • Shimomura, I., Bashmakov, Y., and Horton, J.D., 1999. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. The journal of biological chemistry, 274 (42), 30028–30032.
  • Shimomura, I., et al., 1998. Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. The journal of biological chemistry, 273 (52), 35299–35306.
  • Srinivasan, K., et al., 2004. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods and findings in experimental and clinical pharmacology, 26 (5), 327–333.
  • Stein, E.A., Lane, M., and Laskarzewski, P., 1998. Comparison of statins in hypertriglyceridemia. The American journal of cardiology, 81 (4), 66B–69B.
  • Tam, S.P., et al., 1991. Differences between the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and low density lipoprotein receptor in human hepatoma cells and fibroblasts reside primarily at the translational and post-translational levels. The journal of biological chemistry, 266 (25), 16764–16773.
  • Wang, X., et al., 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell, 77 (1), 53–62.
  • Wang, Z., et al., 2019. Apolipoprotein A-IV involves in glucose and lipid metabolism of rat. Nutrition & metabolism, 16, 41. [Internet]. Available from: https://pubmed.ncbi.nlm.nih.gov/31303888.
  • Wierzbicki, A.S., Poston, R., and Ferro, A., 2003. The lipid and non-lipid effects of statins. Pharmacology & therapeutics, 99 (1), 95–112.
  • Woo, M.N., Bok, S.H., and Choi, M.S., 2009. Hypolipidemic and body fat-lowering effects of Fatclean in rats fed a high-fat diet. Food and chemical toxicology: an international journal published for the British industrial biological research association, 47 (8), 2076–2082.
  • Xiao, X. and Song, B.-L., 2013. SREBP: a novel therapeutic target. Acta biochimica et biophysica sinica, 45 (1), 2–10.
  • Xu, J., et al., 1999. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids a mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. The journal of biological chemistry, 274 (33), 23577–23583.
  • Xu, Y., et al., 2007. The characteristics of living and behavioral factors in Chinese patients with metabolic syndrome. Journal of health science, 53 (1), 84–91.
  • Yellaturu, C.R., et al., 2009. Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. The journal of biological chemistry, 284 (12), 7518–7532.
  • Yokoyama, C., et al., 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell, 75 (1), 187–197.
  • Zhang, L., et al., 1999. The preventive effects of incomplete Freund's adjuvant and other vehicles on the development of adjuvant-induced arthritis in Lewis rats. Immunology, 98 (2), 267–272.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.